Valheart Dosage/Direction for Use

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Dosage/Direction for Use

General Dosing Recommendations: Ivabradine dosage must be individualized according to patient's heart rate response and closely monitored by a physician.
Ivabradine tablet must be taken orally twice a day (morning and evening) with meals. (See table.)

Click on icon to see table/diagram/image

Dosage in Elderly Patients (≥75 years old): Lower initial dose of 2.5 mg twice a day should be considered, before increasing if necessary.
Dosage in Patients with Hepatic Impairment: No dosage adjustment is necessary required in patients with mild or moderate hepatic impairment. Ivabradine is contraindicated in patients with severe hepatic impairment.
Dosage in Patients with Renal Impairment: No dosage adjustment is necessary in patients with creatinine clearance of 15 to 60 mL/min. There are no data available in patients with creatinine clearance below 15 mL/min.

Valheart Dosage/Direction for Use

ivabradine

Manufacturer:

KRKA

Distributor:

UNILAB, Inc